Mortality due to septic shock following early, appropriate antibiotic therapy: Can we do better?

Critical Care Medicine

Volumn 40, Issue 7, 2012, Pages 2228-2229

  Kethireddy, Shravan ^a   Kumar, Anand ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Mortality; sepsis; shock; therapyThe authors have not disclosed any potential conflicts of interest

Indexed keywords

ANTIBIOTIC AGENT; BACTERICIDE;

ANTIBIOTIC THERAPY; COMBINATION CHEMOTHERAPY; EARLY INTERVENTION; EDITORIAL; HOSPITAL INFECTION; HUMAN; INFECTION PREVENTION; INFECTION RISK; INTENSIVE CARE UNIT; MONOTHERAPY; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; SURVIVAL RATE;

FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; SHOCK, SEPTIC;

EID: 84862740335     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e318256bb99     Document Type: Editorial

References (9)

1. Martin GS, Mannino DM, Eaton S, et al: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348:1546-1554 (Pubitemid 36437931)
2. Angus DC, Linde-Zwirble WT, Lidicker J, et al: Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29:1303-1310 (Pubitemid 32641789)
3. Ibrahim EH, Sherman G, Ward S, et al: The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118:146-155 (Pubitemid 30485502)
4. Kumar A, Roberts D, Wood KE, et al: Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34:1589-1596 (Pubitemid 43810035)
5. Labelle A, Juang P, Reichley R, et al: The determinants of hosptial mortality among patients with septic shock receiving appropriate initial antibiotic treatment. Crit Care Med 2012; 40:2016-2021
6. Posteraro B, DePascale G, Tumbarello M, et al: Early diagnosis of candidemia in intensive care unit patients with sepsis: A prospective comparison of (1-3) B-D-glucan assay, Candida score, and colonization index. Crit Care 2001; 15:1-10
7. Bouadma L, Luyt CE, Tubach F, et al; PRORATA trial group: Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): A multicentre randomised controlled trial. Lancet 2010; 375:463-474
8. Jensen JU, Heslet L, Jensen TH, et al: Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med 2006; 34:2596-2602 (Pubitemid 44413058)
9. Kumar A, Safdar N, Kethireddy S, et al: A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: A meta-analytic/meta-regression study. Crit Care Med 2010; 38:1651-1664